This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting on Oct 27, 2026 to consider Q2 FY27 results
JUBLINGREA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Ingrevia has informed BSE that its Board of Directors will meet on Tuesday, October 27, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The results will also be posted on the company's website. No financial figures or business details were disclosed in this intimation.
Routine pre-results announcement; no immediate impact on the stock. Watch for the Q2 FY27 earnings on October 27.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹1,394 Cr | ₹1,121 Cr | +24.4% |
| Operating profit | ₹139.0 Cr | ₹82.13 Cr | +69.2% |
| Profit after tax | ₹111.4 Cr | ₹69.47 Cr | +60.4% |
| EBITDA margin | 15.2% | 12.1% | +3.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.